NET Power Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NET Power Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $250.0K | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | $175.0K | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $580.0K | Mar 11, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $219.0K | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | $172.0K | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $305.0K | Mar 11, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($578.63M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($49.19M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | ($43.06M) | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | ($34.18M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($54.78M) | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | ($9.80M) | Mar 2, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.79B) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($181.32M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | ($193.51M) | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | ($34.15M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($50.03M) | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | ($697.1K) | Mar 2, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.51M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $63.85M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $25.72M | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | $14.31M | Mar 10, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($120.78M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($31.65M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | ($38.38M) | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | ($10.62M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($16.63M) | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | ($1.33M) | Mar 2, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.21M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $68.65M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $9.22M | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | $2.43M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $115.0K | Mar 11, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $599.70M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.29B | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.47B | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $78.14M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $348.37M | Mar 2, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.50M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $131.93M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $140.14M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $13.74M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $42.32M | Mar 2, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($39.31M) | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | ($38.56M) | Mar 2, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $359.85M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $423.92M | Mar 9, 2026 |
| FY2023 | Jun 7, 2023 | $433.74M | Mar 11, 2024 |
| FY2023 | Dec 31, 2022 | $0 | Mar 11, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($694.67M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($116.04M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | ($66.85M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($224.53M) | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | ($38.56M) | Mar 2, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.43M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $329.23M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $536.93M | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | $7.95M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $5.16M | Mar 11, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (7) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | (9) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | (14) | Mar 11, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (7) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 10, 2025 |
| FY2024 | Jun 7, 2023 | (9) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | (14) | Mar 11, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | 3.72M | Mar 11, 2024 |